FR2825928B1 - Composition pharmaceutique pour le diagnostic, la prevention ou le traitement d'une pathologie tumorale, comprenant un agent modulateur de l'etat polymerisation de l'actine - Google Patents
Composition pharmaceutique pour le diagnostic, la prevention ou le traitement d'une pathologie tumorale, comprenant un agent modulateur de l'etat polymerisation de l'actineInfo
- Publication number
- FR2825928B1 FR2825928B1 FR0107976A FR0107976A FR2825928B1 FR 2825928 B1 FR2825928 B1 FR 2825928B1 FR 0107976 A FR0107976 A FR 0107976A FR 0107976 A FR0107976 A FR 0107976A FR 2825928 B1 FR2825928 B1 FR 2825928B1
- Authority
- FR
- France
- Prior art keywords
- actin
- diagnosing
- polymerization
- preventing
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0107976A FR2825928B1 (fr) | 2001-06-18 | 2001-06-18 | Composition pharmaceutique pour le diagnostic, la prevention ou le traitement d'une pathologie tumorale, comprenant un agent modulateur de l'etat polymerisation de l'actine |
EP02745538A EP1432732A2 (fr) | 2001-06-18 | 2002-06-18 | Composition pharmaceutique comprenant un agent modulateur de l'etat de polymerisation de l'actine |
PCT/FR2002/002106 WO2002102846A2 (fr) | 2001-06-18 | 2002-06-18 | Composition pharmaceutique comprenant un agent modulateur de l'etat de polymerisation de l'actine |
AU2002317259A AU2002317259A1 (en) | 2001-06-18 | 2002-06-18 | Pharmaceutical composition for diagnosis, prevention or treatment of a tumorous state, comprising a modulator of the actin polymerisation state |
CA002450845A CA2450845A1 (fr) | 2001-06-18 | 2002-06-18 | Composition pharmaceutique pour le diagnostic, la prevention ou le traitement d'une pathologie tumorale, comprenant un agent modulateur de l'etat de polymerisation de l'actine |
JP2003506318A JP4271026B2 (ja) | 2001-06-18 | 2002-06-18 | アクチン重合状態の調節剤を含む腫瘍病変の診断、予防又は治療用の薬剤組成物 |
US10/740,266 US20040191230A1 (en) | 2001-06-18 | 2003-12-18 | Pharmaceutical composition for the diagnosis, prevention or treatment of a tumoral pathology comprising an agent modulating the polymerization state of actin |
US12/426,833 US20090286720A1 (en) | 2001-06-18 | 2009-04-20 | Pharmaceutical composition for the diagnosis, prevention or treatment of a tumoral pathology comprising an agent modulating the polymerization state of actin |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0107976A FR2825928B1 (fr) | 2001-06-18 | 2001-06-18 | Composition pharmaceutique pour le diagnostic, la prevention ou le traitement d'une pathologie tumorale, comprenant un agent modulateur de l'etat polymerisation de l'actine |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2825928A1 FR2825928A1 (fr) | 2002-12-20 |
FR2825928B1 true FR2825928B1 (fr) | 2004-04-02 |
Family
ID=8864451
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR0107976A Expired - Fee Related FR2825928B1 (fr) | 2001-06-18 | 2001-06-18 | Composition pharmaceutique pour le diagnostic, la prevention ou le traitement d'une pathologie tumorale, comprenant un agent modulateur de l'etat polymerisation de l'actine |
Country Status (7)
Country | Link |
---|---|
US (2) | US20040191230A1 (fr) |
EP (1) | EP1432732A2 (fr) |
JP (1) | JP4271026B2 (fr) |
AU (1) | AU2002317259A1 (fr) |
CA (1) | CA2450845A1 (fr) |
FR (1) | FR2825928B1 (fr) |
WO (1) | WO2002102846A2 (fr) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0224014D0 (en) * | 2002-10-15 | 2002-11-27 | Oxford Glycosciences Uk Ltd | A protein involved in therapy |
EP1841316B1 (fr) * | 2005-01-10 | 2011-04-27 | Rosalind Franklin University of Medicine and Science | CCN3 protéine pour son utilisation dans le traitement et le diagnostic des maladies rénales |
US7780949B2 (en) * | 2005-01-10 | 2010-08-24 | Rosalind Franklin University Of Medicine And Science | Regulation of CCN2 by CCN3 and its therapeutic and diagnostic potential in fibrosis, sclerosis and other diseases |
CA2691251A1 (fr) * | 2007-06-19 | 2008-12-24 | Yoshikazu Ohta | Medicament preventif/remede contre le cancer |
WO2010095940A2 (fr) * | 2009-02-20 | 2010-08-26 | To-Bbb Holding B.V. | Sustème d'administration de médicament à base de glutathionne |
EP2552462B1 (fr) | 2010-04-02 | 2015-12-16 | Rosalind Franklin University of Medicine and Science | Peptides ccn3 à visée thérapeutique et leurs analogues |
US9114112B2 (en) | 2010-04-02 | 2015-08-25 | Rosalind Franklin University Of Medicine And Science | CCN3 and CCN3 peptides and analogs thereof for therapeutic uses |
US10028906B2 (en) | 2016-03-22 | 2018-07-24 | Rosalind Franklin University Of Medicine And Science | Method and kit for treating a solid tumor and associated desmoplasia |
CN109628452A (zh) * | 2019-01-17 | 2019-04-16 | 浙江大学 | 一种抑制肿瘤细胞增殖和迁移的Zyxin基因shRNA及重组载体与应用 |
CN111620939B (zh) * | 2019-10-25 | 2021-01-01 | 南京市妇幼保健院 | 一种用于治疗或辅助治疗卵巢癌的多肽zyx36-58 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6586425B2 (en) * | 1996-02-21 | 2003-07-01 | Wisconsin Alumni Research Foundation | Cytoskeletal active agents for glaucoma therapy |
US5856330A (en) * | 1996-07-31 | 1999-01-05 | Hoechst Aktiengesellschaft | Use of xanthine derivatives for the inhibition of dephosphorylation of cofilin |
JP2001525535A (ja) * | 1997-09-04 | 2001-12-11 | ボード オブ トラスティーズ オブ レランド スタンフォード ジュニア ユニバーシティ | 細胞骨格機能のモジュレーターを検出するためのアッセイ |
AU773420B2 (en) * | 1998-12-11 | 2004-05-27 | Medarex, Inc. | Prodrug compounds and process for preparation thereof |
CA2325806A1 (fr) * | 1999-12-03 | 2001-06-03 | Molecular Mining Corporation | Methodes de diagnostique et de pronostic de leucemies aigues |
FR2806805A1 (fr) * | 2000-03-22 | 2001-09-28 | Centre Nat Rech Scient | SEQUENCE PEPTIDIQUES COMPRENANT UN OU PLUSIEURS MOTIFS DE LIAISON AUX PROTEINES DE LA FAMILLE Ena/VASP, ET LEURS UTILISATIONS |
-
2001
- 2001-06-18 FR FR0107976A patent/FR2825928B1/fr not_active Expired - Fee Related
-
2002
- 2002-06-18 JP JP2003506318A patent/JP4271026B2/ja not_active Expired - Fee Related
- 2002-06-18 AU AU2002317259A patent/AU2002317259A1/en not_active Abandoned
- 2002-06-18 EP EP02745538A patent/EP1432732A2/fr not_active Withdrawn
- 2002-06-18 CA CA002450845A patent/CA2450845A1/fr not_active Abandoned
- 2002-06-18 WO PCT/FR2002/002106 patent/WO2002102846A2/fr active Application Filing
-
2003
- 2003-12-18 US US10/740,266 patent/US20040191230A1/en not_active Abandoned
-
2009
- 2009-04-20 US US12/426,833 patent/US20090286720A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CA2450845A1 (fr) | 2002-12-27 |
US20040191230A1 (en) | 2004-09-30 |
AU2002317259A1 (en) | 2003-01-02 |
WO2002102846A2 (fr) | 2002-12-27 |
JP4271026B2 (ja) | 2009-06-03 |
WO2002102846A3 (fr) | 2004-04-22 |
US20090286720A1 (en) | 2009-11-19 |
FR2825928A1 (fr) | 2002-12-20 |
JP2005504521A (ja) | 2005-02-17 |
EP1432732A2 (fr) | 2004-06-30 |
WO2002102846B1 (fr) | 2004-06-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA26790A1 (fr) | Composition dietetique ou pharmaceutique a l'usage pour la prevention ou le traitement de la hyper-oxalurie | |
FR2825928B1 (fr) | Composition pharmaceutique pour le diagnostic, la prevention ou le traitement d'une pathologie tumorale, comprenant un agent modulateur de l'etat polymerisation de l'actine | |
MA26420A1 (fr) | Compositions pharmaceutiques mixtes pour le traitement de l'osteoporose, et procede pour leur preparation. | |
DE69434726D1 (de) | Polymer zur therapeutischen Anwendung | |
MA26889A1 (fr) | Composition pharmaceutique pour le traitement de la douleur aigue chronique et/ ou neuropathique et des migraines | |
TNSN99053A1 (fr) | Hydroxamides d'acides (4-arylsulfonylamino)-tetrahydro- pyranne-4-carboxyliques), procede pour leur preparation et compositions les contenant | |
FR2721043B1 (fr) | Emulsion de bitume, mélange à froid la contenant et procédé pour le traitement de surface. | |
TNSN99055A1 (fr) | Derives bicycliques d'acide hydroxamique nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant | |
TNSN04097A1 (fr) | Formulations comprenant une cephalosporine et leur utilisation dans le traitement d'infections bacteriennes chez les chats et les chiens. | |
BR0109650A (pt) | 3-cianoquinolinas, 3-ciano-1,6-naftiridinas e 3-ciano-1,7-naftiridinas como inibidores da cinase proteìca | |
IL125735A (en) | Pharmaceutical compositions for the treatment of glaucoma comprising an inhibitor of serine-threonine kinase, tyrosine kinase or protein tyrosine phosphatase or an actin-disrupting compound | |
BR9709915A (pt) | Composto composição farmacêutica utilização do composto e processos para o tratamento ou a prevençao de distúrbios fisiológicos asociados com um excesso de taquiquininas e para preparação do composto | |
DZ1877A1 (fr) | Forme posologiques d'azithromycine pour le traitement d'infection microbiennes. | |
TNSN96104A1 (fr) | Trihydrate de metahensulfonate de (1s,2s)-1-(4-hydroxyphenyl) -2-(4-hydroxy-4-phenylpiperidine-1-yl)-1-propanol et composition pharmaceutique le contenant | |
BR9711194A (pt) | Uso de agente quelante clioquinol para a fabricação de uma composição farmacêutica para o tratamento de doença de alzheimer. | |
DZ2675A1 (fr) | Association pharmaceutique pour le traitement d'undysfunctionnement sexuel et compositions la conte nant. | |
BR9611897A (pt) | Benzofurano carboxamidas e sulfonamidas | |
BR9805801A (pt) | Quelatos metálicos de derivados macrocìclicos poliaminocarboxìlicos e sua aplicação em formação de imagem para diagnóstico | |
MA26608A1 (fr) | Procede de preparation d'une composition pharmaceutique destinee au traitement de l'insuffisance cardiaque. | |
TNSN99001A1 (fr) | Indoles 2,3-substitues servant d'agents anti-inflammatoires et analgesiques | |
DZ3014A1 (fr) | Médicaments pour le traitement de l'hypertension. | |
FR2642972B1 (fr) | Agents pour le diagnostic et le traitement des melanomes, derives halogenes aromatiques utilisables comme de tels agents et leur preparation | |
EP0734725A3 (fr) | Adjuvants contenant des composés de fer colloidaux | |
FR2831539B1 (fr) | Utilisation d'alkylpolyglycosides comme agents emulsionnants pour la preparation d'emulsion huile-dans eau contenant des charges ou pigments mineraux, et emulsions huile-dans-eau contenant de tels alkylpolyglycosides | |
ATE233812T1 (de) | Peptide mit pronociceptiveigenschaften |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse |
Effective date: 20140228 |